BILL · 2025–26 SESSION

HB 2613: Compounded medications

Establishing safety and regulatory requirements for compounded medications.

Summary

Prohibits entities from selling, transferring, or distributing compounded drugs that use bulk drug substances unless the compounder complies with certain quality assurance requirements.

From the House Bill Analysis 2026 (HB 2613), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee

AN ACT Relating to establishing safety and regulatory requirements for compounded medications;

No recorded floor votes. This measure never reached a floor vote.

Bill numbers restart every two years, so the same number is a different bill in each session.

HB 2613 (2019–20) Unemployment benefits · Enacted · Chapter 86, Laws of 2020
HB 2613 (2017–18) Dev. disability employment · Did not pass · died in committee
HB 2613 (2015–16) Clean vehicle tax exemptions · Did not pass · died in committee
HB 2613 (2013–14) Higher ed efficiencies · Enacted · Chapter 162, Laws of 2014
HB 2613 (2011–12) Innovative industries · Did not pass · died in committee
HB 2613 (2009–10) Signature gathering · Did not pass · died in committee
HB 2613 (2007–08) State facility cleaning · Did not pass · passed House, stalled in Senate
HB 2613 (2005–06) Discovery in a criminal case · Did not pass · died in committee